Latest Tissue plasminogen activator Stories
Patients who are treated with a new clot-removal device after suffering an acute ischemic stroke have significantly reduced disability levels after the event, according to new research led by Dr. Jeffery Saver of the UCLA Stroke Center and the David Geffen School of Medicine.
GLASGOW, April 17, 2015 /PRNewswire/ -- The European Stroke Organisation (ESO), at the first annual European Stroke Organisation Conference (ESOC 2015), in Glasgow, April
HOUSTON, March 16, 2015 /PRNewswire-USNewswire/ -- Houston Methodist Willowbrook Hospital has received the American Heart Association/American Stroke Association's Get With The Guidelines(®)-Stroke
By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique.
ESCAPE, EXTEND IA show treatment allows more patients to live independently, return to everyday life WASHINGTON, Feb.
- Vepoloxamer alone and in combination with tPA improved neurologic function and reduced brain tissue loss compared to tPA alone and saline controls SAN DIEGO, Feb.
THR-18 significantly decreases the occurrence of intracranial hemorrhage and brain edema, and enhances recovery in acute ischemic stroke patients REHOVOT, Israel, December 18, 2014 /PRNewswire/
Swedish Medical Center leads the way in effectively treating nation's fourth leading cause of death DENVER, Dec.
Study is most significant stroke treatment clinical trial since NINDS-2 says Society of NeuroInterventional Surgery WASHINGTON, Dec.
Leader in Emergency Medicine and Medical Ventures NEW YORK, Nov. 11, 2014 /PRNewswire/ -- Vesselon, Inc. today announced the appointment of Paul S.
- Growing in low tufty patches.